TY - CHAP AU - Mathers, C. D. AU - Lopez, A. D. AU - Murray, C. J. L. ED - Lopez, A. D. ED - Mathers, C. D. ED - Ezzati, M. ED - Jamison, D. T. ED - Murray, C. J. L. PY - 2006 DA - 2006// TI - The burden of disease and mortality by condition: data, methods and results for 2001 BT - Global Burden of Disease and Risk Factors PB - The World Bank and Oxford University Press CY - New York ID - Mathers2006 ER - TY - JOUR AU - Murray, R. M. AU - Lappin, J. AU - Di, F. M. PY - 2008 DA - 2008// TI - Schizophrenia: from developmental deviance to dopamine dysregulation JO - Eur Neuropsychopharmacol VL - 18 UR - https://doi.org/10.1016/j.euroneuro.2008.04.002 DO - 10.1016/j.euroneuro.2008.04.002 ID - Murray2008 ER - TY - JOUR AU - Meltzer, H. Y. AU - Matsubara, S. AU - Lee, J. C. PY - 1989 DA - 1989// TI - Classification of typical and atypical antipsychotic drugs on the basis of Dopamine D-1, D-2 and Serotonin2 Pki Values JO - J Pharmacol Exp Ther VL - 251 ID - Meltzer1989 ER - TY - JOUR AU - Horacek, J. AU - Bubenikova-Valesova, V. AU - Kopecek, M. AU - Palenicek, T. AU - Dockery, C. AU - Mohr, P. AU - Höschl, C. PY - 2006 DA - 2006// TI - Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia JO - CNS Drugs VL - 20 UR - https://doi.org/10.2165/00023210-200620050-00004 DO - 10.2165/00023210-200620050-00004 ID - Horacek2006 ER - TY - JOUR AU - Takeuchi, H. AU - Suzuki, T. AU - Bies, R. R. AU - Remington, G. AU - Mamo, D. C. AU - Pollock, B. G. AU - Mimura, M. AU - Uchida, H. PY - 2013 DA - 2013// TI - Estimated dopamine D2 receptor occupancy from plasma concentrations of atypical antipsychotics and subjective experience/drug attitude in schizophrenia: an analysis of the CATIE data JO - Schizophr Res VL - 150 UR - https://doi.org/10.1016/j.schres.2013.08.033 DO - 10.1016/j.schres.2013.08.033 ID - Takeuchi2013 ER - TY - JOUR AU - Moriguchi, S. AU - Bies, R. R. AU - Remington, G. AU - Suzuki, T. AU - Mamo, D. C. AU - Watanabe, K. AU - Mimura, M. AU - Pollock, B. G. AU - Uchida, H. PY - 2013 DA - 2013// TI - Estimated dopamine D2 receptor occupancy and remission in schizophrenia: analysis of the CATIE data JO - J Clin Psychopharmacol VL - 33 UR - https://doi.org/10.1097/JCP.0b013e3182979a0a DO - 10.1097/JCP.0b013e3182979a0a ID - Moriguchi2013 ER - TY - JOUR AU - Tsuboi, T. AU - Bies, R. R. AU - Suzuki, T. AU - Mamo, D. C. AU - Pollock, B. G. AU - Graff-Guerrero, A. AU - Mimura, M. AU - Uchida, H. PY - 2013 DA - 2013// TI - Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data JO - Prog Neuropsychopharmacol Biol Psychiatry VL - 45 UR - https://doi.org/10.1016/j.pnpbp.2013.05.010 DO - 10.1016/j.pnpbp.2013.05.010 ID - Tsuboi2013 ER - TY - JOUR AU - Kielbasa, W. AU - Stratford, R. E. PY - 2012 DA - 2012// TI - Exploratory translational modeling approach in drug development to predict human brain pharmacokinetics and pharmacologically relevant clinical doses JO - Drug Metab Dispos VL - 40 UR - https://doi.org/10.1124/dmd.111.043554 DO - 10.1124/dmd.111.043554 ID - Kielbasa2012 ER - TY - JOUR AU - Johnson, M. AU - Kozielska, M. AU - Pilla Reddy, V. AU - Vermeulen, A. AU - Li, C. AU - Grimwood, S. AU - de Greef, R. AU - Groothuis, G. M. AU - Danhof, M. AU - Proost, J. H. PY - 2011 DA - 2011// TI - Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats JO - Pharm Res VL - 28 UR - https://doi.org/10.1007/s11095-011-0477-7 DO - 10.1007/s11095-011-0477-7 ID - Johnson2011 ER - TY - JOUR AU - Kozlelska, M. AU - Johnson, M. AU - Pilla Reddy, V. AU - Vermeulen, A. AU - Li, C. AU - Grimwood, S. AU - de Greef, R. AU - Groothuis, G. M. AU - Danhof, M. AU - Proost, J. H. PY - 2012 DA - 2012// TI - Phamacokinetic-Pharmacodynamic modeling of the D2 and 5-HT(2A) receptor occupancy of risperidone and paliperidone in rats JO - Pharm Res VL - 29 UR - https://doi.org/10.1007/s11095-012-0722-8 DO - 10.1007/s11095-012-0722-8 ID - Kozlelska2012 ER - TY - JOUR AU - de Lange, E. C. M. AU - Ravenstijn, P. G. M. AU - Groenendaal, D. AU - van Steeg, T. S. PY - 2005 DA - 2005// TI - Towards the prediction of CNS drug effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling JO - AAPS J VL - 7 UR - https://doi.org/10.1208/aapsj070354 DO - 10.1208/aapsj070354 ID - de Lange2005 ER - TY - JOUR AU - de Lange, E. C. M. PY - 2013 DA - 2013// TI - The mastermind approach to CNS drug therapy: Translational prediction of human brain distribution, target site kinetics and therapeutic effects JO - Fluids and Barriers of the CNS VL - 10 UR - https://doi.org/10.1186/2045-8118-10-12 DO - 10.1186/2045-8118-10-12 ID - de Lange2013 ER - TY - JOUR AU - Cremers, T. I. F. H. AU - Flik, G. AU - Hofland, C. AU - Stratford, R. E. PY - 2012 DA - 2012// TI - Microdialysis evaluation of clozapine and n-desmethylclozapine pharmacokinetics in rat brain JO - Drug Metab Dispos VL - 40 UR - https://doi.org/10.1124/dmd.112.045682 DO - 10.1124/dmd.112.045682 ID - Cremers2012 ER - TY - STD TI - Holford NHG: Wings for NONMEM. [http://wfn.sourceforge.net/] UR - http://wfn.sourceforge.net/ ID - ref14 ER - TY - JOUR AU - Savic, R. M. AU - Jonker, D. M. AU - Kerbusch, T. AU - Karlsson, M. O. PY - 2007 DA - 2007// TI - Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies JO - J Pharmacokinet Pharmacodyn VL - 34 UR - https://doi.org/10.1007/s10928-007-9066-0 DO - 10.1007/s10928-007-9066-0 ID - Savic2007 ER - TY - JOUR AU - Fridén, M. AU - Gupta, A. AU - Antonsson, M. AU - Bredberg, U. AU - Hammarlund-Udenaes, M. PY - 2007 DA - 2007// TI - In vitro methods for estimating unbound drug concentrations in brain interstitial and intracellular fluids JO - Drug Metab Dispos VL - 35 UR - https://doi.org/10.1124/dmd.107.015222 DO - 10.1124/dmd.107.015222 ID - Fridén2007 ER - TY - JOUR AU - Feng, Y. AU - Pollock, B. G. AU - Ferrell, R. E. AU - Kimak, M. A. AU - Reynold, C. F. AU - Bies, R. R. PY - 2006 DA - 2006// TI - Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling JO - Br J Clin Pharmacol VL - 61 UR - https://doi.org/10.1111/j.1365-2125.2006.02629.x DO - 10.1111/j.1365-2125.2006.02629.x ID - Feng2006 ER - TY - JOUR AU - Sharma, V. AU - McNeill, J. H. PY - 2009 DA - 2009// TI - To scale or not to scale: the principles of dose extrapolation JO - Br J Clin Pharmacol VL - 157 UR - https://doi.org/10.1111/j.1476-5381.2009.00267.x DO - 10.1111/j.1476-5381.2009.00267.x ID - Sharma2009 ER - TY - JOUR AU - Centorrino, F. AU - Baldessarrrini, R. J. AU - Kando, J. C. AU - Frankenburg, F. R. AU - Volpicelli, S. A. AU - Flood, J. G. PY - 1994 DA - 1994// TI - Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients JO - J Clin Psychopharmacol VL - 14 UR - https://doi.org/10.1097/00004714-199404000-00006 DO - 10.1097/00004714-199404000-00006 ID - Centorrino1994 ER - TY - JOUR AU - Raedler, T. J. AU - Hinkelmann, K. AU - Wiedemann, K. PY - 2008 DA - 2008// TI - Variability of the in vitro metabolism of clozapine JO - Clin Neuropharmacol VL - 31 UR - https://doi.org/10.1097/WNF.0b013e31815cba61 DO - 10.1097/WNF.0b013e31815cba61 ID - Raedler2008 ER - TY - JOUR AU - Couchman, L. AU - Morgan, P. E. AU - Spencer, E. P. AU - Flanagan, R. J. PY - 2010 DA - 2010// TI - Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: Data from a therapeutic drug monitoring service, 1993–2007 JO - Ther Drug Monit VL - 32 UR - https://doi.org/10.1097/FTD.0b013e3181dad1fb DO - 10.1097/FTD.0b013e3181dad1fb ID - Couchman2010 ER - TY - JOUR AU - Ismail, Z. AU - Wessels, A. AU - Ucbida, H. AU - Ng, W. AU - Mamo, D. C. AU - Rajji, T. K. AU - Pollock, B. G. AU - Mulsant, B. H. AU - Bies, R. R. PY - 2012 DA - 2012// TI - Age and sex impact clozapine plasma concentrations in inpatients and outpatients with schizophrenia JO - Am J Geriatr Psychiatry VL - 20 UR - https://doi.org/10.1097/JGP.0b013e3182118318 DO - 10.1097/JGP.0b013e3182118318 ID - Ismail2012 ER - TY - CHAP PY - 2013 DA - 2013// BT - Clinical Pharmacology [database online] ID - ref23 ER - TY - JOUR AU - Seeman, P. T. PY - 2002 DA - 2002// TI - Atypical antipsychotics:mechanism of action JO - Can J Psychiatry VL - 47 ID - Seeman2002 ER - TY - JOUR AU - Bymaster, F. P. AU - Calligaro, D. O. AU - Falcone, J. F. AU - Marsh, R. D. AU - Moore, N. A. AU - Tye, N. C. AU - Seeman, P. AU - Wong, D. T. PY - 1996 DA - 1996// TI - Radioreceptor binding profile of the atypical antipsychotic olanzapine JO - Neuropsychopharmacology VL - 14 UR - https://doi.org/10.1016/0893-133X(94)00129-N DO - 10.1016/0893-133X(94)00129-N ID - Bymaster1996 ER - TY - JOUR AU - Kroeze, W. K. AU - Hufeisen, S. J. AU - Popadak, B. A. AU - Renock, S. M. AU - Steinberg, S. AU - Ernsberger, P. AU - Jayathilake, K. AU - Meltzer, H. Y. AU - Roth, B. L. PY - 2003 DA - 2003// TI - H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs JO - Neuropsychopharmacology VL - 28 UR - https://doi.org/10.1038/sj.npp.1300027 DO - 10.1038/sj.npp.1300027 ID - Kroeze2003 ER - TY - BOOK AU - Lidow, M. S. PY - 2000 DA - 2000// TI - Neurotransmitter Receptors in Actions of Antipsychotic Medications PB - CRC Press CY - Boca Raton, FL UR - https://doi.org/10.1201/9781420041774 DO - 10.1201/9781420041774 ID - Lidow2000 ER - TY - JOUR AU - Doran, A. AU - Obach, R. S. AU - Smith, B. J. AU - Hosea, N. A. AU - Becker, S. AU - Callegari, E. AU - Chen, C. AU - Chen, X. AU - Choo, E. AU - Cuabfrigba, J. AU - Cox, L. M. AU - Gibbs, J. P. AU - Gibbs, M. A. AU - Hatch, H. AU - Hop, C. E. AU - Kasman, I. N. AU - Laperle, J. AU - Liu, J. AU - Liu, X. AU - Logman, M. AU - Maclin, D. AU - Nedza, F. M. AU - Nelson, F. AU - Olson, E. AU - Rahematpura, S. AU - Raunig, D. AU - Rogers, S. AU - Schmidt, K. AU - Spracklin, D. K. AU - Szewc, M. PY - 2005 DA - 2005// TI - The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model JO - Drug Metab Dispos VL - 33 UR - https://doi.org/10.1124/dmd.104.001230 DO - 10.1124/dmd.104.001230 ID - Doran2005 ER - TY - JOUR AU - Olsen, C. K. AU - Brennum, L. T. AU - Kreilgaard, M. PY - 2008 DA - 2008// TI - Using pharmacokinetic-pharmacodynamic modelling as a tool forprediction of therapeutic effective plasma levels of antipsychotics JO - Eur J Pharmacol VL - 584 UR - https://doi.org/10.1016/j.ejphar.2008.02.005 DO - 10.1016/j.ejphar.2008.02.005 ID - Olsen2008 ER - TY - JOUR AU - Nordström, A. L. AU - Farde, L. AU - Nyberg, S. AU - Karlsson, P. AU - Halldin, C. AU - Sedvall, G. PY - 1995 DA - 1995// TI - D1, D2, and 5–HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenia JO - Am J Psychiatry VL - 152 UR - https://doi.org/10.1176/ajp.152.10.1444 DO - 10.1176/ajp.152.10.1444 ID - Nordström1995 ER - TY - JOUR AU - Bishara, D. AU - Taylor, D. PY - 2008 DA - 2008// TI - Upcoming agents for the treatment of schizophrenia: mechanism of action, efficacy and tolerability JO - Drugs VL - 68 UR - https://doi.org/10.2165/0003495-200868160-00002 DO - 10.2165/0003495-200868160-00002 ID - Bishara2008 ER -